HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nikolaos Grigoriadis Selected Research
Nikolaos Grigoriadis Research Topics
Disease
33
Multiple Sclerosis
07/2023 - 07/2007
19
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2024 - 12/2003
17
Inflammation (Inflammations)
05/2024 - 01/2005
15
Relapsing-Remitting Multiple Sclerosis
01/2023 - 07/2002
12
Demyelinating Diseases (Demyelinating Disease)
07/2023 - 12/2009
12
Neuroinflammatory Diseases
01/2023 - 03/2006
8
Stroke (Strokes)
10/2022 - 08/2008
8
Tauopathies
01/2022 - 10/2006
8
Alzheimer Disease (Alzheimer's Disease)
01/2019 - 10/2006
7
Traumatic Brain Injuries (Traumatic Brain Injury)
10/2013 - 03/2006
6
Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 10/2006
5
Atrophy
04/2024 - 01/2002
5
Infections
03/2024 - 01/2009
5
Neoplasms (Cancer)
07/2023 - 01/2003
5
Gliosis
01/2023 - 10/2006
5
Disease Progression
11/2020 - 06/2008
4
Neuromyelitis Optica (Devic's Disease)
12/2022 - 03/2010
4
Brain Diseases (Brain Disorder)
01/2021 - 04/2008
4
Encephalitis (Encephalitis, Rasmussen)
08/2010 - 12/2003
4
Closed Head Injuries
12/2009 - 03/2006
3
Obesity
03/2024 - 01/2023
3
COVID-19
01/2023 - 01/2021
3
Fatigue
02/2022 - 10/2004
3
Wounds and Injuries (Trauma)
12/2009 - 07/2007
2
Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2024 - 02/2017
2
Encephalomyelitis (Myeloencephalitis)
10/2023 - 02/2006
2
Autism Spectrum Disorder
05/2023 - 06/2019
2
Nervous System Diseases (Neurological Disorders)
01/2023 - 10/2013
2
Chronic Progressive Multiple Sclerosis
01/2022 - 01/2020
2
Neurologic Manifestations (Neurological Manifestations)
09/2021 - 10/2006
2
Progressive Multifocal Leukoencephalopathy
01/2021 - 08/2011
2
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 02/2017
2
Cognitive Dysfunction
06/2020 - 01/2017
2
Autistic Disorder (Autism)
01/2020 - 01/2019
2
Pathologic Processes
01/2018 - 01/2017
2
Thrombosis (Thrombus)
01/2015 - 01/2015
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2014 - 08/2008
2
Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2013 - 07/2009
2
Dementia (Dementias)
07/2011 - 03/2009
2
Autoimmune Diseases (Autoimmune Disease)
12/2009 - 01/2005
2
Scrapie
07/2009 - 10/2006
2
Central Nervous System Diseases (CNS Diseases)
07/2007 - 12/2003
1
Cerebellar Diseases (Cerebellar Syndrome)
05/2024
1
Spinal Muscular Atrophy (Progressive Muscular Atrophy)
05/2024
1
Muscular Atrophy (Muscle Atrophy)
05/2024
1
Hyperhomocysteinemia
03/2024
1
Dysbiosis
03/2024
1
Atrial Fibrillation
03/2024
1
Hypertension (High Blood Pressure)
03/2024
1
Atherosclerosis
03/2024
1
Dyslipidemias (Dyslipidemia)
03/2024
1
Diabetes Mellitus
03/2024
1
Insulin Resistance
03/2024
1
Mood Disorders (Mood Disorder)
07/2023
Drug/Important Bio-Agent (IBA)
13
Proteins (Proteins, Gene)
FDA Link
05/2024 - 01/2007
7
Biomarkers (Surrogate Marker)
IBA
12/2022 - 01/2019
6
Peptides (Polypeptides)
IBA
01/2019 - 01/2005
5
Antibodies
IBA
05/2024 - 07/2009
4
Nogo Receptors
IBA
01/2023 - 10/2016
4
Ligands
IBA
01/2023 - 01/2005
4
Natalizumab (Tysabri)
FDA Link
01/2021 - 08/2011
4
Amyloid (Amyloid Fibrils)
IBA
07/2011 - 10/2006
3
Galectin 3 (LGALS3)
IBA
03/2024 - 01/2020
3
Vaccines
IBA
01/2023 - 01/2021
3
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2023 - 01/2016
3
Neutralizing Antibodies
IBA
01/2023 - 01/2016
3
Chemokines
IBA
12/2022 - 12/2015
3
Cytokines
IBA
12/2022 - 07/2011
3
nitazoxanide (NTZ)
FDA Link
01/2021 - 01/2016
3
tau Proteins (tau Protein)
IBA
10/2013 - 10/2006
3
Antigens
IBA
07/2007 - 01/2005
2
Nogo Receptor 1
IBA
01/2023 - 01/2021
2
Enzymes
IBA
01/2023 - 09/2021
2
Complement C5 (Complement 5)
IBA
01/2023 - 01/2023
2
Complement System Proteins (Complement)
IBA
01/2023 - 01/2023
2
Myelin-Oligodendrocyte Glycoprotein
IBA
12/2022 - 11/2020
2
Retinaldehyde (Retinal)
IBA
12/2022 - 07/2022
2
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
02/2022 - 06/2021
2
Interferons
IBA
01/2022 - 01/2016
2
Immunoglobulin G (IgG)
IBA
02/2021 - 01/2009
2
Metalloproteases (Metalloproteinases)
IBA
07/2019 - 02/2018
2
Caspase 3 (Caspase-3)
IBA
11/2018 - 12/2009
2
Lectins
IBA
01/2018 - 03/2009
2
Interferon-beta
IBA
01/2016 - 07/2002
2
Prion Proteins
IBA
01/2013 - 07/2009
2
Therapeutic Uses
IBA
07/2011 - 01/2011
2
DNA (Deoxyribonucleic Acid)
IBA
07/2007 - 03/2006
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2007 - 03/2006
1
Lipopolysaccharides
IBA
05/2024
1
Stathmin
IBA
03/2024
1
Indicators and Reagents (Reagents)
IBA
03/2024
1
Adipokines
IBA
03/2024
1
Lipoprotein(a)
IBA
03/2024
Therapy/Procedure
20
Therapeutics
07/2023 - 03/2007
8
Transplantation
01/2022 - 12/2003
6
Immunomodulation
10/2023 - 06/2008
5
Immunotherapy
07/2023 - 10/2006
3
Cognitive Training
06/2020 - 01/2017
2
Denervation
01/2003 - 01/2002
1
Polypharmacy
07/2023